Pharmacological treatment of osteoarthritis in the elderly;Medikamentöse arthrosetherapie im alter

Zeitschrift fur Rheumatologie

Volumn 64, Issue 7, 2005, Pages 467-472

  Brabant, Th ^a   Stichtenoth, D ^b  

^a Krankenhaus St Joseph Stift Bremen   (Germany)

^b HANNOVER MEDICAL SCHOOL   (Germany)

Author keywords

Age associated side effects; Osteoarthritis; Polymorbidity

Indexed keywords

ANALGESIC AGENT; CLOPIDOGREL; CODEINE; CYCLOOXYGENASE 2 INHIBITOR; DICLOFENAC; DIHYDROCODEINE; FENTANYL; GLUCOCORTICOID; HYDROMORPHONE; IBUPROFEN; INDOMETACIN; MELOXICAM; MISOPROSTOL; MORPHINE; NALOXONAZINE; NONSTEROID ANTIINFLAMMATORY AGENT; OPIATE; OXYCODONE; PARACETAMOL; PROTON PUMP INHIBITOR; ROFECOXIB; TILIDINE; TRAMADOL;

AGED; ANALGESIA; ARTICLE; CARDIOVASCULAR RISK; DISABILITY; DISEASE COURSE; DISEASE PREDISPOSITION; FUNCTIONAL DISEASE; GASTROINTESTINAL SYMPTOM; HUMAN; JOINT FUNCTION; KIDNEY DISEASE; OSTEOARTHRITIS; PAIN; SURGICAL TECHNIQUE;

AGED; AGED, 80 AND OVER; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ANTIRHEUMATIC AGENTS; ARTHRALGIA; GERIATRICS; HUMANS; OSTEOARTHRITIS; PHYSICIAN'S PRACTICE PATTERNS; PRACTICE GUIDELINES; TREATMENT OUTCOME;

EID: 27144439001     PISSN: 03401855     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00393-005-0778-5     Document Type: Article

References (32)

1. ACR American College of Rheumatology subcommittee on osteoarthritis guidelines Recommendations for the medical management of osteoarthritis of the hip and knee; update (2000) Arthritis Rheum 43:1905-1915
2. Basler HD, Hesselbarth S, Kaluzza G, Schuler M, Sohn W, Nikolaus Th (2003) Komorbidität, Multimedikation und Befinden bei älteren Menschen mit chronischen Schmerzen, Schmerz 17:252-260
3. Bjordal JM, Ljunggren AE, Klovning A, Slerdal L (2005) NSAIDs, including coxibs probably do more harm than good, and paracetamol is ineffective for hip osteoarthritis. Ann Rheum Dis 64(4):655-656
4. Cockroft DW, Gault MH (1976) Prediction of creatinin clearance from serum creatinine. Nephron 16:31
5. David E (1987) Schmerz im höheren Lebensalter. In: Schmidt KL (Hrsg) Physikalische Medizin, Balneotherapie und Rehabilitation im höheren Lebensalter. Steinkopf 13-19
6. Dawson J, Linsell L, Zondervan K, Rose P, Carr A, Randall T, Fitzpatrick R (2005) Impact of persistent Hip or Knee Pain an Overall Health Status in Elderly People: A Longitudinal Population study Arthritis & Rheumatism (Arthritis Care and Research) 53(3):368-374
7. Felson DT, Zhang Y (1988) An update on the epidemiology of hip and knee osteoarthritis with a view to prevention. Arthritis Rheum 41(8):1343-1355
8. Gossec L, Dougados M (2004) Intra-articular treatments in osteoarthritis: From the symptomatic to the structure modifying Ann Rheum Dis 63:478-482
9. Graham DJ, Campen D, Hui R, et al (2005) Risk of acute myocardial infarction and sudden cardiac death in patients treated with cyclo-oxygenase 2 selective and non-selective non-steroidal anti-inflammatory drugs: nested case-control study. Lancet 365:475-481
10. Griffin MR, Piper JM, Daugherty JR, Snowden M, Ray WA (1991) Non-steroidal anti-inflammatory drug use and increased risk for peptic ulcer disease in elderly persons. Ann Intern Med 114:257-263
11. Gunzelmann T, Schumacher J, Brähler E (2002) Prävalenz von Schmerzen im Alter: Ergebnisse repräsentativer Befragungen der deutschen Altenbevölkerung mit dem Giessener Beschwerdebogen. Schmerz 16:318-328
12. Hackenbroch M (2002) Arthrosen. Georg Thieme Verlag Stuttgart New York, 58-59
13. Hippisley-Cox J, Coupland C (2005) Risk of myocardial infarction in patients taking cyclo-oxygenase-2 inhibitors or conventional non-steroidal anti-inflammatory drugs: population based nested case-control analysis. BMJ 330:1366
14. Hochberg MC, Altmann RD, Brandt KD, Clark BM, Dieppe PA, Griffin MR, Moskowitz RW, Schnitzer TJ (1995) Guidelines for the medical management of osteoarthritis. Part II Osteoarthritis of the knee American College of Rheumatology. Arthritis Rheum 38(11):1541-1546
15. Köhler L, Stichtenoth DO, Frölich JC, Zeidler H (1999) Therapie rheumatischer Erkrankungen. In: Platt D, Mutschler E (Hrsg.): Pharmakotherapie im Alter. Wissenschaftliche Verlagsgesellschaft, Stuttgart, 187-204
16. Kurth T, Glynn RJ, Walker AM, Chan KA, Buring JE, Hennekens CH, Gaziano JM (2003) Inhibition of clinical benefits of aspirin on first myocardial infarction by nonsteroidal antiinflammatory drugs. Circulation 108:1191-1195
17. Laine L, Connors LG, Reicin A, Hawkey CJ, Burgos-Vargas R, Schnitzer TJ et al (2003) Serious lower gastrointestinal clinical events with nonselective NSAID or Coxib use. Gastroenterology 124:288-292
18. Lehmann L, Stöwe J (2004) Aktuelle Aspekte zur Ätiologie und Therapie des Arthroseschmerzes, Schmerz 18:453-462
19. Levesque LE, Brophy JM, Zhang B (2005) The Risk for Myocardial Infarction with Cyclooxygenase-2 Inhibitors: A Population Study of Elderly Adults. Ann Intern Med 142:481-489
20. Loeser RF Jr (2000) Rheumatic disease Clinics of North America Geriatric Rheumatology 26(3):547-569
21. Mamdani M, Juurlink DN, Lee DS, Rochon PA, Kopp A, Naglie G (2004) Cyclo-oxygenase-2 inhibitors versus non-selective non-steroidal anti-inflammatory drugs and congestive heart failure outcomes in elderly patients: a population-based cohort study. Lancet 363:1751-1756
22. Nurdan K, Bozkurt P, Ozcan H, Toktas H, Koran B (2005) A prospective randomised controlled clinical trial comparing the efficacy of different molecular weight hyaluron an solutions in the treatment of knee osteoarthritis Rheumatology International Springer Verlag. Published online
23. Platt D, Mühlberg D (1994) (Arzneimitteltherapie im Alter. Internist 35:955
24. Ray WA, Stein CM, Daugherty JR, Hall K, Arbogast PG, Griffin MR (2002) COX-2 selective non-steroidal anti-inflammatory drugs and risk of serious coronary heart disease. Lancet 360:1071-1073
25. Stichtenoth DO, Frölich JC (2001) Therapie mit präferentiellen und spezifischen COX-2-Inhibitoren. Internist 42:421-426
26. Stichtenoth DO (2005) Therapie mit NSAR im höheren Lebensalter. Eur J Ger 7:117-127
27. Stöwe J (2005) Konservative Therapie der Arthrose. Orthopäde 34:613-622
28. Towheed T, Shea B, Wells G, Hochberg M (2000) Analgesia and non-aspirin, non-steroidal anti-inflammatory drugs for osteoarthritis of the hip Cochrane Database. Syst Rev 2
29. Weil J, Colin-Jones D, Langman M, Lawson D, Logan R, Murphy M et al (1995) Prophylactic aspirin and risk of peptic ulcer bleeding. BMJ 310:827-830
30. Wessel D (2003) Medikamentöse Behandlung älterer Rheumatiker. Arthritis und Rheuma (23):259-267
31. Wollenhaupt J (2003) Gerontorheumatologie, Thieme Verlag Stuttgart. New York, 42
32. Zhang W, Doherty M, Arden N, Bannwarth B, Bijlsma J, Gunther K-P et al (2004) Eular evidence based recommendations for the management of hip osteoarthritis: report of a task force of the Eular Standing Committee for International Clinical Studies including Therapeutics (ESCISIT) Ann Rheum Dis. Published Online First